Bolt Biotherapeutics Share Price Today
(NASDAQ: BOLT)

Name: Bolt Biotherapeutics Share Price Today (NASDAQ: BOLT) - Bolt Biotherapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Bolt Biotherapeutics share price is $0.36 & ₹30.49 as on 1 May 2025, 2.30 'hrs' IST

$0.36

▲

0.01

(1.51%)

Market is closed - opens 7 PM, 01 May 2025

View live Bolt Biotherapeutics share price in Dollar and Rupees. Guide to invest in Bolt Biotherapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bolt Biotherapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Bolt Biotherapeutics share price movements

Today's Low: $0.35
Today's High: $0.37
$0.36
3.47%
Downside
Day's Volatility :6.08%
Upside
2.7%
52 Weeks Low: $0.30
52 Weeks High: $1.34
$0.36
16.67%
Downside
52 Weeks Volatility :77.53%
Upside
73.03%

Bolt Biotherapeutics (BOLT) Returns

Period	Bolt Biotherapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-28.42%	-5.5%	0.0%
6 Months	-43.28%	-6.0%	0.0%
1 Year	-67.86%	-0.8%	0.0%
3 Years	-76.92%	6.9%	-5.1%

Bolt Biotherapeutics (BOLT) Key Statistics

in dollars & INR

Previous Close	$0.35
Open	$0.351
Today's High	$0.37
Today's Low	$0.3475
Market Capitalization	$14.2M
Today's Volume	$198.7K
52 Week High	$1.335
52 Week Low	$0.3
Revenue TTM	$7.7M
EBITDA	$-66.5M
Earnings Per Share (EPS)	$-1.65
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-74.28%

How to invest in Bolt Biotherapeutics Stock (BOLT) from India?

It is very easy for Indian residents to invest directly in Bolt Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bolt Biotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bolt Biotherapeutics or BOLT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bolt Biotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bolt Biotherapeutics shares which would translate to 2.352 fractional shares of Bolt Biotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bolt Biotherapeutics, in just a few clicks!

Returns in Bolt Biotherapeutics (BOLT) for Indian investors in Rupees

The Bolt Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Bolt Biotherapeutics investment value today

Current value as on today

₹33,629

Returns

₹66,371

(-66.37%)

Returns from Bolt Biotherapeutics Stock

₹67,857 (-67.86%)

Dollar Returns

₹1,486 (+1.49%)

Indian investors sentiment towards Bolt Biotherapeutics (BOLT)

-52%

Period: Mar 31, 2025 to Apr 30, 2025. Change in 30 Days versus previous period

Search interest for Bolt Biotherapeutics Stock from India on INDmoney has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Bolt Biotherapeutics

TANG CAPITAL MANAGEMENT LLC
9.94%
Vivo Capital, LLC
9.18%
Sofinnova Ventures
7.18%
Pivotal bioVenture Partners Investment Advisor LLC
4.93%
Vanguard Group Inc
2.78%
Samsara BioCapital, LLC
2.74%

Analyst Recommendation on Bolt Biotherapeutics

Rating

Trend

Buy

83%Buy

16%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Bolt Biotherapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Bolt Biotherapeutics Stock (BOLT)

What analysts predicted

Upside of 212.5%

Target:

$1.13

Current:

$0.36

Insights on Bolt Biotherapeutics Stock (Ticker Symbol: BOLT)

Price Movement
In the last 1 year, BOLT stock has moved down by -67.4%
Decreasing Revenue
Revenue is down for the last 3 quarters, 5.27M → 1.14M (in $), with an average decrease of 43.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -15.17M → -15.93M (in $), with an average decrease of 5.0% per quarter
BOLT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 78.7% return, outperforming this stock by 146.1%
BOLT vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 92.8% return, outperforming this stock by 169.7%
Price to Sales
ForBOLT every $1 of sales, investors are willing to pay $1.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Bolt Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Bolt Biotherapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bolt Biotherapeutics (BOLT) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bolt Biotherapeutics Inc	-10.0%	-43.28%	-67.86%	-76.92%	-98.88%
Biontech Se	14.33%	-7.95%	15.74%	-28.71%	127.41%
Regeneron Pharmaceuticals, Inc.	-7.79%	-32.13%	-37.03%	-12.75%	5.0%
Vertex Pharmaceuticals Incorporated	3.75%	5.66%	25.06%	91.98%	90.0%
Alnylam Pharmaceuticals, Inc.	0.61%	-3.48%	71.59%	85.05%	88.33%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bolt Biotherapeutics Inc	NA	NA	NA	-1.4	-0.74	-0.33	NA	1.49
Biontech Se	160.8	NA	0.04	-5.11	-0.03	-0.04	NA	80.89
Regeneron Pharmaceuticals, Inc.	15.94	15.94	0.96	39.38	0.16	0.07	0.01	273.57
Vertex Pharmaceuticals Incorporated	32.84	NA	1.35	17.95	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.72	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bolt Biotherapeutics Inc	Buy	$14.2M	-98.88%	NA	0.0%
Biontech Se	Buy	$29.5B	127.41%	160.8	-24.18%
Regeneron Pharmaceuticals, Inc.	Buy	$66.5B	5.0%	15.94	31.07%
Vertex Pharmaceuticals Incorporated	Buy	$127.6B	90.0%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.0B	88.33%	NA	-12.37%

About Bolt Biotherapeutics

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company dBDC-3042, develops dan agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer; and BDC-4182, an next-generation boltbody technology platform that targets claudin 18.2, which is overexpressed in gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc.; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Organization	Bolt Biotherapeutics
Employees	52
CEO	Mr. William P. Quinn
Industry	Healthcare

Management People of Bolt Biotherapeutics

Name	Title
Mr. William P. Quinn	CEO, CFO, President, Secretary & Director
Mr. Grant Yonehiro C.F.A., M.B.A.	COO & Chief Business Officer
Ms. Sarah Nemec	Senior VP of Finance & Principal Accounting Officer
Mr. Wesley Burwell	VP & Head of Human Resources
Dr. Nathan Ihle Ph.D.	Senior Vice President of Pharmaceutical Operations
Dr. Michael N. Alonso Ph.D.	Senior Vice President of Research

Important FAQs about investing in BOLT Stock from India :

What is Bolt Biotherapeutics share price today?

Bolt Biotherapeutics share price today stands at $0.36, Open: $0.35 ; Previous Close: $0.35 ; High: $0.37 ; Low: $0.35 ; 52 Week High: $1.34 ; 52 Week Low: $0.30.

The stock opens at $0.35, after a previous close of $0.35. The stock reached a daily high of $0.37 and a low of $0.35, with a 52-week high of $1.34 and a 52-week low of $0.30.

Can Indians buy Bolt Biotherapeutics shares?

Yes, Indians can invest in the Bolt Biotherapeutics (BOLT) from India.

With INDmoney, you can buy Bolt Biotherapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Bolt Biotherapeutics at zero transaction cost.

How can I buy Bolt Biotherapeutics shares from India?

It is very easy to buy Bolt Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bolt Biotherapeutics (BOLT) be purchased?

Yes, you can buy fractional shares of Bolt Biotherapeutics with INDmoney app.

What are the documents required to start investing in Bolt Biotherapeutics stocks?

To start investing in Bolt Biotherapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.